Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.

Genital psoriasis affects 2-5% of psoriasis patients; generalised plaque or intertriginous psoriasis also affects the genital area in 29-40% of cases. Anogenital psoriasis has been associated with significant quality of life impairments, but little is known about specific patient needs/treatment goa...

Full description

Bibliographic Details
Main Authors: Neuza da Silva, Matthias Augustin, Anna Langenbruch, Ulrich Mrowietz, Kristian Reich, Diamant Thaçi, Wolf-Henning Boehncke, Natalia Kirsten, Alexandra Danckworth, Rachel Sommer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0235091
_version_ 1819142775817371648
author Neuza da Silva
Matthias Augustin
Anna Langenbruch
Ulrich Mrowietz
Kristian Reich
Diamant Thaçi
Wolf-Henning Boehncke
Natalia Kirsten
Alexandra Danckworth
Rachel Sommer
author_facet Neuza da Silva
Matthias Augustin
Anna Langenbruch
Ulrich Mrowietz
Kristian Reich
Diamant Thaçi
Wolf-Henning Boehncke
Natalia Kirsten
Alexandra Danckworth
Rachel Sommer
author_sort Neuza da Silva
collection DOAJ
description Genital psoriasis affects 2-5% of psoriasis patients; generalised plaque or intertriginous psoriasis also affects the genital area in 29-40% of cases. Anogenital psoriasis has been associated with significant quality of life impairments, but little is known about specific patient needs/treatment goals. This study aimed to examine the overall and sex-related disease burden, patient needs and treatment benefits in patients with anogenital psoriasis, compared to patients with psoriasis not affecting the anal/genital areas. Within the cross-sectional nationwide survey, 2,009 participants were consecutively recruited in 157 randomly assigned German dermatology practices and clinics, according to the following inclusion criteria aged 18 years or over; diagnosis of psoriasis vulgaris; ability to answer the questionnaires; and written informed consent. Based on a high-resolution grid on the topical distribution of psoriasis, two groups were formed: anogenital psoriasis (n = 622) and comparison group (n = 1,303). Clinical severity was assessed by the Psoriasis Area and Severity Index (PASI). Patients completed the EuroQoL visual analogue scale (EQ VAS), the Dermatology Life Quality Index (DLQI), and the Patient Benefit Index (PBI). Patients with anogenital psoriasis had higher PASI (13.0±10.6 vs. 8.9±7.6, P < 0.001) and more DLQI impairments (8.9±6.9 vs. 7.0±6.2, P = 0.002) than controls. At the item-level, they also reported more sex-related DLQI impairments (DLQI-i9: 0.5±0.8 vs. 0.3±0.7, P < 0.001) and treatment needs (PBI-i17: 2.2±1.8 vs. 1.9±1.8, P = 0.001). A great percentage of missing/not-relevant responses was found for sex-related items (23.3-41.9%). These results suggest that the assessment of sex-related impairments and treatment needs should be prioritised in patients with anogenital psoriasis. Questionnaires may be used as a less uncomfortable way for patients to discuss their genital lesions and sexual function during healthcare visits. However, the great percentage of missing/not-relevant responses to sex-related items calls for in-depth assessments and effective patient-physician communication regarding these sensitive topics.
first_indexed 2024-12-22T12:15:43Z
format Article
id doaj.art-b051c812b79743bca5d04af826ff1144
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T12:15:43Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b051c812b79743bca5d04af826ff11442022-12-21T18:26:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01157e023509110.1371/journal.pone.0235091Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.Neuza da SilvaMatthias AugustinAnna LangenbruchUlrich MrowietzKristian ReichDiamant ThaçiWolf-Henning BoehnckeNatalia KirstenAlexandra DanckworthRachel SommerGenital psoriasis affects 2-5% of psoriasis patients; generalised plaque or intertriginous psoriasis also affects the genital area in 29-40% of cases. Anogenital psoriasis has been associated with significant quality of life impairments, but little is known about specific patient needs/treatment goals. This study aimed to examine the overall and sex-related disease burden, patient needs and treatment benefits in patients with anogenital psoriasis, compared to patients with psoriasis not affecting the anal/genital areas. Within the cross-sectional nationwide survey, 2,009 participants were consecutively recruited in 157 randomly assigned German dermatology practices and clinics, according to the following inclusion criteria aged 18 years or over; diagnosis of psoriasis vulgaris; ability to answer the questionnaires; and written informed consent. Based on a high-resolution grid on the topical distribution of psoriasis, two groups were formed: anogenital psoriasis (n = 622) and comparison group (n = 1,303). Clinical severity was assessed by the Psoriasis Area and Severity Index (PASI). Patients completed the EuroQoL visual analogue scale (EQ VAS), the Dermatology Life Quality Index (DLQI), and the Patient Benefit Index (PBI). Patients with anogenital psoriasis had higher PASI (13.0±10.6 vs. 8.9±7.6, P < 0.001) and more DLQI impairments (8.9±6.9 vs. 7.0±6.2, P = 0.002) than controls. At the item-level, they also reported more sex-related DLQI impairments (DLQI-i9: 0.5±0.8 vs. 0.3±0.7, P < 0.001) and treatment needs (PBI-i17: 2.2±1.8 vs. 1.9±1.8, P = 0.001). A great percentage of missing/not-relevant responses was found for sex-related items (23.3-41.9%). These results suggest that the assessment of sex-related impairments and treatment needs should be prioritised in patients with anogenital psoriasis. Questionnaires may be used as a less uncomfortable way for patients to discuss their genital lesions and sexual function during healthcare visits. However, the great percentage of missing/not-relevant responses to sex-related items calls for in-depth assessments and effective patient-physician communication regarding these sensitive topics.https://doi.org/10.1371/journal.pone.0235091
spellingShingle Neuza da Silva
Matthias Augustin
Anna Langenbruch
Ulrich Mrowietz
Kristian Reich
Diamant Thaçi
Wolf-Henning Boehncke
Natalia Kirsten
Alexandra Danckworth
Rachel Sommer
Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.
PLoS ONE
title Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.
title_full Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.
title_fullStr Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.
title_full_unstemmed Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.
title_short Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.
title_sort sex related impairment and patient needs benefits in anogenital psoriasis difficult to communicate topics and their impact on patient centred care
url https://doi.org/10.1371/journal.pone.0235091
work_keys_str_mv AT neuzadasilva sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT matthiasaugustin sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT annalangenbruch sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT ulrichmrowietz sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT kristianreich sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT diamantthaci sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT wolfhenningboehncke sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT nataliakirsten sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT alexandradanckworth sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare
AT rachelsommer sexrelatedimpairmentandpatientneedsbenefitsinanogenitalpsoriasisdifficulttocommunicatetopicsandtheirimpactonpatientcentredcare